SKK
CSBR icon

Shepherd Kaplan Krochuk’s Champions Oncology CSBR Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-21,564
Closed -$78K – 229
2018
Q1 		$78K Sell
21,564
-17,000
-44% -$63.4K 0.05% 227
2017
Q4 		$150K Sell
38,564
-2,500
-6% -$8.91K 0.09% 201
2017
Q3 		$156K Hold
41,064
– – 0.13% 162
2017
Q2 		$106K Buy
41,064
+17,000
+71% +$44.4K 0.06% 195
2017
Q1 		$76K Sell
24,064
-31,500
-57% -$110K 0.04% 226
2016
Q4 		$141K Buy
55,564
+27,564
+98% +$53.7K 0.04% 198
2016
Q3 		$47K Buy
+28,000
New +$52.1K 0.01% 357

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Shepherd Kaplan Krochuk's CSBR Position: Q2 2018 in Review

Shepherd Kaplan Krochuk sold out of Champions Oncology (CSBR) in Q2 2018, closing a stake of 21,564 shares — an estimated $78K sold.

Shepherd Kaplan Krochuk first reported a position in CSBR in Q3 2016 and held it in 7 quarters. The position peaked at $156K in Q3 2017. 18 funds tracked by Wall St. Rank hold CSBR as of Q2 2018.

  • Shepherd Kaplan Krochuk reported no remaining Champions Oncology position as of Q2 2018 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 21,564 Champions Oncology shares in Q2 2018, an estimated $78K.
  • Shepherd Kaplan Krochuk first reported a position in Champions Oncology in Q3 2016 and held it in 7 quarters.
  • Shepherd Kaplan Krochuk's Champions Oncology position peaked at $156K in Q3 2017.
  • 18 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2018.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2018, filed 14 Aug 2018.